In early March, Molycorp Inc. (NYSE: MCP) demonstrated a focus on integration within rare-earth (RE) mining initiatives with their $1.3 billion... Read More
Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and BioNTech. The... Read More
Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and BioNTech. The... Read More